Deciphera Pharmaceuticals (DCPH) Stock Jumps 85%: How Does it Score?


Deciphera Pharmaceuticals (DCPH) stock is up more than 85% Tuesday and has risen 4.32% over the last 12 months. The average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives DCPH stock a score of 69 out of a possible 100.

That score is mainly influenced by a short-term technical score of 94. DCPH’s score also includes a long-term technical score of 92. The fundamental score for DCPH is 19. In addition to the average rating from Wall Street analysts, DCPH stock has a mean target price of $40.25. This means analysts expect the stock to gain 9.05% over the next 12 months.

Click Here to get the full Stock Score Report on Deciphera Pharmaceuticals Inc (DCPH).

What’s Happening with DCPH Stock Today

Deciphera Pharmaceuticals Inc (DCPH) stock is higher by 85.01% while the S&P 500 has risen 1.45% as of 10:54 AM on Tuesday, Aug 13. DCPH has risen $16.96 from the previous closing price of $19.95 on volume of 6,609,987 shares. Over the past year the S&P 500 is up 3.65% while DCPH has risen 4.32%. DCPH lost -$3.31 per share in the over the last 12 months.

Symbols: DCPH

You May Also Like